UNITED BIOMEDICAL INC

Insider Reports History

Reporting-owner location: Hauppauge, NY
Latest reporting-owner signature: /s/ Mei Mei Hu, As Director and Officer
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for UNITED BIOMEDICAL INC

Form 4 holding 10%+ Owner

Vaxxinity, Inc.

Security class: Class A common stock
Shares / value: 51,737,344
Estimated value: $86,401,364
Report date: 16 Jun 2022
Price: $1.67
Ownership: Direct

Form 4 holding 10%+ Owner

Vaxxinity, Inc.

Security class: Class A common stock
Shares / value: 4,212,495
Estimated value: $7,034,867
Report date: 16 Jun 2022
Price: $1.67
Ownership: Held by United Biomedical Inc., Asia

Insider Reports Filed by UNITED BIOMEDICAL INC

4

Vaxxinity, Inc.

Report period: 16 Jun 2022
Transactions: 1
Transaction value: +$199,290
Accepted by SEC: 21 Jun 2022, 16:52
Role: 10%+ Owner
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 08 Jun 2022
Transactions: 2
Transaction value: +$59,386
Accepted by SEC: 10 Jun 2022, 18:14
Role: 10%+ Owner
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 26 Apr 2022
Transactions: 2
Transaction value: +$79,689
Accepted by SEC: 28 Apr 2022, 19:35
Role: 10%+ Owner
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 25 Apr 2022
Transactions: 1
Transaction value: +$27,073
Accepted by SEC: 27 Apr 2022, 20:36
Role: 10%+ Owner
Next action: Open filing details

4

Vaxxinity, Inc.

Report period: 15 Nov 2021
Transactions: 4
Transaction value: $0
Accepted by SEC: 15 Nov 2021, 17:59
Role: 10%+ Owner
Next action: Open filing details

3

Vaxxinity, Inc.

Report period: 10 Nov 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 10 Nov 2021, 15:58
Role: 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .